Seres Therapeutics
MCRB
MCRB
74 hedge funds and large institutions have $341M invested in Seres Therapeutics in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $344M → $341M (-$2.68M)
6% less funds holding
Funds holding: 79 → 74 (-5)
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
Holders
74
Holding in Top 10
1
Calls
$1.3M
Puts
$390K
Top Buyers
| 1 | +$1.68M | |
| 2 | +$1.53M | |
| 3 | +$1.24M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$389K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$371K |
Top Sellers
| 1 | -$2.85M | |
| 2 | -$1.17M | |
| 3 | -$817K | |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$641K |
| 5 |
SIM
Spark Investment Management
New York
|
-$613K |